Taysha Gene Therapies Inc (TSHA) Q3 2024 Earnings Call Highlights: Clinical Progress and ...

By Yahoo! Finance | Nov 14, 2024 at 02:16 AM EST

Taysha Gene Therapies is considering using patients as their own controls in trials for Rett syndrome, focusing on milestones and functional gains. They are leveraging natural history data to inform trial design and endpoints, aiming for consistent improvement.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.